معرفی
Ioannis Spiliotis is a Clinical Researcher at the Oxford Centre for Diabetes, Endocrinology and Metabolism (University of Oxford) and a Consultant in Diabetes, Endocrinology, and General Medicine at Milton Keynes University Hospital NHS Trust. He holds a DPhil from the University of Oxford and is affiliated with the Rorsman Group.
Education:
- BSc (Hons) in Molecular Biology
- MBBS (medical degree)
- MRCP (Membership of the Royal College of Physicians)
- DPhil (PhD) in Islet Physiology
His research focuses on glucagon secretion in diabetes, pharmacological interventions (e.g., sulfonylureas, SGLT2 inhibitors), and translating in vitro findings to clinical trials. Key projects include the LEGEND-D trial for Type 1 Diabetes and studies on MODY.
Recent publications highlight his work on hyperglucagonemia, insulin secretion, and SGLT2 inhibition in diabetes. He has led clinical trials such as DEPTH and Glucagon in MODY (NCT03246828).
He collaborates with the clinical islet transplantation team at Churchill Hospital and integrates molecular biology with endocrinology in his research.
